SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $4,236,000 | -51.1% | 68,000 | -44.3% | 0.19% | -42.8% |
Q1 2017 | $8,671,000 | -75.7% | 122,000 | -89.0% | 0.33% | -78.0% |
Q1 2016 | $35,704,000 | +2.3% | 1,113,654 | +86.0% | 1.52% | +7.4% |
Q4 2015 | $34,913,000 | +27.1% | 598,854 | -7.7% | 1.42% | +33.1% |
Q3 2015 | $27,468,000 | +23.4% | 649,064 | +112.8% | 1.06% | +43.3% |
Q2 2015 | $22,265,000 | -25.6% | 305,000 | -48.8% | 0.74% | -23.4% |
Q1 2015 | $29,909,000 | +211.2% | 595,443 | +126.7% | 0.97% | +180.9% |
Q4 2014 | $9,612,000 | -32.3% | 262,625 | -41.7% | 0.34% | -33.3% |
Q3 2014 | $14,196,000 | – | 450,667 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |